Wescoe Lecture Series
Our Wescoe Lecture Series offers patients, care partners, and healthcare professionals the opportunity to stay informed about the latest developments in pulmonary fibrosis patient care. Held throughout the year, these virtual sessions feature leading expert speakers covering a range of topics, from treatment updates and clinical trials to wellness strategies and patient resources. Participants gain valuable knowledge, practical tools, and a sense of connection within the pulmonary fibrosis community.
December 2026 Lecture
Beyond the Cough: Chronic Cough in Pulmonary Fibrosis and the Future of Research
Date: Monday, December 7, 2026
Time: 12:00 – 1:30 PM EST
Presented by: Ross Summer, MD – Ludwig A. Kind Professor of Medicine – CEO, Jane & Leonard Korman Respiratory Institute – Division Chief, Pulmonary, Allergy, & Critical Care Medicine
November 2026 Lecture
Honoring Veterans, Advancing Care: Understanding Military Exposures, Interstitial Lung Disease, and Pathways to Support
Date: Wednesday, November 11, 2026 (Veterans Day!)
Time: 12:00 – 1:30 PM EST
Presented by: Daniel Kotok, MD – Pulmonologist – ILD/PH Specialist, Mr. Roy Smith – Lieutenant Colonel USAF (Retired) – Vietnam Veteran
September 2026 Lecture
What’s in the Bottle? Understanding Branded & Unbranded Pulmonary Fibrosis Medications
Date: Tuesday, September 29, 2026
Time: 12:00 – 1:30 PM EST
Presented by: Izma Zahir – PharmD, Nader Alramli – PharmD, Orsini Specialty Pharmacy
June 2026 Lecture
Breathing Together: Understanding PAP, Pulmonary Fibrosis & Where They Meet
Date: Wednesday, June 24, 2026
Time: 11:00 AM EST
Presented by: Dr. Cormac McCarthy – University College Dublin, Jennifer Wescoe – Wescoe Foundation, Kelsea Arford – PAP Alliance
April & May 2026 Lecture
First Lecture: PPF & IPF: Unpacking the Alphabet Soup of Pulmonary Fibrosis
Date: Wednesday, April 22nd, 2026
Time: 1:00 – 2:30 PM EST
Presented by: Lisa Lancaster, MD – Chief Medical Officer Endeavor BioMedicines, Medical Director of the Interstitial Lung Disease Program and Associate Professor of Medicine at Vanderbilt University
Second Lecture: MIST Clinical Trial: Studying the Inhaled Pirfenidone in the Treatment of Progressive Pulmonary Fibrosis
Date: Tuesday, May 5th, 2026
Time: 12:00 – 1:00 PM EST
Presented by: Rebecca Weaver, APRN – Senior Director, Clinical Development, Avalyn Pharma